News

On November 9, 2023, investigators from the CRISPR Cures for Cancer network will present their latest work. Learn how they apply cutting-edge technologies to the design and development of novel therapeutic approaches for cancer.

The first cohort of investigators selected for project funding through the CRISPR Cures for Cancer Initiative were chosen this past July and include researchers at UCSF, Gladstone Institutes, and the Innovative Genomics Institute at UC Berkeley.

Scientists used a new method to screen 10,000 combinations of gene edits in immune cells engineered to fight cancer.

A new study explains how understudied cells in the immune system, called gamma delta T cells, can target cancer cells for destruction.

With a slew of tools to trick out immune cells, researchers are expanding the repertoire of CAR-T therapies.

Researchers at the Gladstone-UCSF Institute of Genomic Immunology are learning how to harness the power of the human immune system in new ways.

A new approach by UCSF researchers analyzes how well different re-engineered T cells work against cancer.

A team of scientists at Gladstone and UCSF developed a new approach using CRISPR to produce massive quantities of cells for therapeutic applications.

A gene not previously known to regulate immunity could turn tired T cells around.

Kole Roybal and his team developed a comprehensive rule book for the design of therapeutic cells with improved specificity and safety, and for the eventual customization of cell-based therapies.